Stay updated on Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision banner updated from v3.5.0 to v3.5.2; the old v3.5.0 label was removed.
    Difference
    0.1%
    Check dated 2026-04-16T18:35:46.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision history updated: a new version v3.5.0 is now listed, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:49:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:56:18.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears to be an administrative update, and the removal of the prior funding-status notice (Revision: v3.4.1) does not affect trial details or patient-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T06:14:48.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding impacts on information currency and facility operations. Updated the page revision to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:36:26.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The updates include adding a glossary toggle and new metadata entries such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T03:44:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Poly-ICLC in MRP Colon Cancer Clinical Trial page.